Stereotactic body radiotherapy was associated with significantly better urinary continence and fewer sexual issues at 2 years ...

Men with localized prostate cancer were randomly assigned to receive either SBRT or control radiotherapy in a phase 3 trial.

In metastatic hormone-sensitive prostate cancer (mHSPC), adding the radioligand 177 Lu-PSMA-617 (Pluvicto) to androgen ...

Prostate cancer is the second leading cause of cancer death among American men. A recent study, conducted by researchers from ...

Prostate cancer poses a significant threat to South African men, especially black men who are at a higher risk. This article ...

Stereotactic body radiotherapy (SBRT) is noninferior to conventional or moderately fractionated radiotherapy for loc ...

More than 52,000 people are diagnosed with prostate cancer every year, making it the most common cancer that affects men.

Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET ...

Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, ...

Being given just six months to live came as a shock to Craig Pankhurst because he assumed not hearing from the doctor about ...

TULSA is a targeted prostate cancer treatment that uses ultrasound to destroy tumors while preserving healthy tissue.

Holy grail’ at-home spit test for prostate cancer raises hopes of reducing heightened risk faced by Black men - Exclusive: ...